Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 25)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
22-Nov-09Reuters Investment ProfileN/AThe Andhra Sugars Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20  View Abstract
20-Nov-09Ford Investor Services, Inc.N/AValue Graph: ANADYS PHARMACEU -- ANDS1$4  View Abstract
20-Nov-09Ford Investor Services, Inc.N/AIndustry Value Graph: ACOR , AFFY , ANDS , BSTC , OMPI , TELK -- DRUGS3$4  View Abstract
10-Nov-09Zacks Investment Research Inc.N/AANADYS PHARMACT (ANDS) Zacks Company Snapshot1$10  View Abstract
10-Nov-09Wright ReportsN/AWright Investors Service Comprehensive Report for Anadys Pharmaceuticals, Inc.40$65  View Abstract
9-Nov-09Zacks Investment Research Inc.N/AANADYS PHARMACT (ANDS) Zacks Company Snapshot1$10  View Abstract
6-Nov-09Zacks Investment Research Inc.N/AANADYS PHARMACT (ANDS) Zacks Company Snapshot1$10  View Abstract
3-Nov-09Zacks Investment Research Inc.N/AANADYS PHARMACT (ANDS) Zacks Company Snapshot1$10  View Abstract
2-Nov-09Zacks Investment Research Inc.N/AANADYS PHARMACT (ANDS) Zacks Company Snapshot1$10  View Abstract
31-Oct-09Zacks Investment Research Inc.N/AANADYS PHARMACT (ANDS) Zacks Company Snapshot1$10  View Abstract
Next 15

Brokerage Reports (Showing 1 to 1 of 1)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
30-Oct-09Thomson StreetEventsN/AANDS - Event Transcript of Anadys Pharmaceuticals, Inc. conference call, Oct. 29, 2009 / 5:00pm ET15$75  View Abstract

Independent Reports (Showing 1 to 10 of 24)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
22-Nov-09Reuters Investment ProfileN/AThe Andhra Sugars Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20View Abstract
20-Nov-09Ford Investor Services, Inc.N/AValue Graph: ANADYS PHARMACEU -- ANDS1$4View Abstract
20-Nov-09Ford Investor Services, Inc.N/AIndustry Value Graph: ACOR , AFFY , ANDS , BSTC , OMPI , TELK -- DRUGS3$4View Abstract
10-Nov-09Zacks Investment Research Inc.N/AANADYS PHARMACT (ANDS) Zacks Company Snapshot1$10View Abstract
10-Nov-09Wright ReportsN/AWright Investors Service Comprehensive Report for Anadys Pharmaceuticals, Inc.40$65View Abstract
9-Nov-09Zacks Investment Research Inc.N/AANADYS PHARMACT (ANDS) Zacks Company Snapshot1$10View Abstract
6-Nov-09Zacks Investment Research Inc.N/AANADYS PHARMACT (ANDS) Zacks Company Snapshot1$10View Abstract
3-Nov-09Zacks Investment Research Inc.N/AANADYS PHARMACT (ANDS) Zacks Company Snapshot1$10View Abstract
2-Nov-09Zacks Investment Research Inc.N/AANADYS PHARMACT (ANDS) Zacks Company Snapshot1$10View Abstract
31-Oct-09Zacks Investment Research Inc.N/AANADYS PHARMACT (ANDS) Zacks Company Snapshot1$10View Abstract
Next 14

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.